Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1112

1.

Chemical Imaging of Evolving Amyloid Plaque Pathology and Associated Aβ Peptide Aggregation in a Transgenic Mouse Model of Alzheimer's Disease.

Michno W, Wehrli P, Meier S, Sehlin D, Syvänen S, Zetterberg H, Blennow K, Hanrieder J.

J Neurochem. 2019 Oct 12. doi: 10.1111/jnc.14888. [Epub ahead of print]

PMID:
31605538
2.

Autocatalytic amplification of Alzheimer-associated Aβ42 peptide aggregation in human cerebrospinal fluid.

Frankel R, Törnquist M, Meisl G, Hansson O, Andreasson U, Zetterberg H, Blennow K, Frohm B, Cedervall T, Knowles TPJ, Leiding T, Linse S.

Commun Biol. 2019 Oct 8;2:365. doi: 10.1038/s42003-019-0612-2. eCollection 2019.

3.

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.

Chatterjee P, Zetterberg H, Goozee K, Lim CK, Jacobs KR, Ashton NJ, Hye A, Pedrini S, Sohrabi HR, Shah T, Asih PR, Dave P, Shen K, Taddei K, Lovejoy DB, Guillemin GJ, Blennow K, Martins RN.

J Neuroinflammation. 2019 Oct 10;16(1):186. doi: 10.1186/s12974-019-1567-4.

4.

Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease.

Kehoe PG, Al Mulhim N, Zetterberg H, Blennow K, Miners JS.

J Alzheimers Dis. 2019 Oct 3. doi: 10.3233/JAD-190721. [Epub ahead of print]

PMID:
31594235
5.

Biomarker-guided clustering of Alzheimer's disease clinical syndromes.

Toschi N, Lista S, Baldacci F, Cavedo E, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Melo Dos Santos A, Epelbaum S, Lamari F, Genthon R, Habert MO, Dubois B, Floris R, Garaci F, Vergallo A, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI).

Neurobiol Aging. 2019 Sep 10;83:42-53. doi: 10.1016/j.neurobiolaging.2019.08.032. [Epub ahead of print]

6.

Plasma neurofilament light chain concentration is increased and correlates with the severity of neuropathy in hereditary transthyretin amyloidosis.

Kapoor M, Foiani M, Heslegrave A, Zetterberg H, Lunn MP, Malaspina A, Gillmore JD, Rossor AM, Reilly MM.

J Peripher Nerv Syst. 2019 Oct 3. doi: 10.1111/jns.12350. [Epub ahead of print]

PMID:
31583784
7.

Plasma pNfH levels differentiate SBMA from ALS.

Lombardi V, Bombaci A, Zampedri L, Lu CH, Malik B, Zetterberg H, Heslegrave AJ, Rinaldi C, Greensmith L, Hanna MG, Malaspina A, Fratta P.

J Neurol Neurosurg Psychiatry. 2019 Oct 1. pii: jnnp-2019-320624. doi: 10.1136/jnnp-2019-320624. [Epub ahead of print] No abstract available.

PMID:
31575607
8.

Switching from a regimen containing abacavir/lamivudine or emtricitabine/tenofovir disoproxil fumarate to emtricitabine/tenofovir alafenamide fumarate does not affect central nervous system HIV-1 infection.

Yilmaz A, Mellgren Å, Fuchs D, Nilsson S, Blennow K, Zetterberg H, Gisslén M.

Infect Dis (Lond). 2019 Sep 26:1-9. doi: 10.1080/23744235.2019.1670352. [Epub ahead of print]

PMID:
31556765
9.

A case series on the value of tau and neurofilament protein levels to predict and detect delirium in cardiac surgery patients.

Saller T, Petzold A, Zetterberg H, Kuhle J, Chappell D, von Dossow V, Klawitter F, Schurholz T, Hagl C, Reuter DA, Zwissler B, Ehler J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Sep;163(3):241-246. doi: 10.5507/bp.2019.043. Epub 2019 Sep 16.

10.

Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data.

Wehrli PM, Michno W, Blennow K, Zetterberg H, Hanrieder J.

J Am Soc Mass Spectrom. 2019 Sep 16. doi: 10.1007/s13361-019-02327-y. [Epub ahead of print]

PMID:
31529404
11.

Acute symptomatic seizures and epilepsy after mechanical thrombectomy.

Eriksson H, Löwhagen Hendén P, Rentzos A, Pujol-Calderón F, Karlsson JE, Höglund K, Blennow K, Zetterberg H, Rosengren L, Zelano J.

Epilepsy Behav. 2019 Sep 13:106520. doi: 10.1016/j.yebeh.2019.106520. [Epub ahead of print]

PMID:
31526644
12.

CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology.

Miners JS, Kehoe PG, Love S, Zetterberg H, Blennow K.

Alzheimers Res Ther. 2019 Sep 14;11(1):81. doi: 10.1186/s13195-019-0534-8.

13.

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease.

Sjödin S, Brinkmalm G, Öhrfelt A, Parnetti L, Paciotti S, Hansson O, Hardy J, Blennow K, Zetterberg H, Brinkmalm A.

Alzheimers Res Ther. 2019 Sep 14;11(1):82. doi: 10.1186/s13195-019-0533-9.

14.

Dementia and CSF-Biomarkers for Alzheimer's Disease Predict Mortality after Acute Hip Fracture.

Dutkiewicz R, Zetterberg H, Andreasson U, Blennow K, Nellgård B.

Acta Anaesthesiol Scand. 2019 Sep 11. doi: 10.1111/aas.13472. [Epub ahead of print]

PMID:
31508810
15.

Sex differences in the genetic predictors of Alzheimer's pathology.

Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, Bush WS, Gifford KA, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Crane PK, Resnick SM, Keene CD, Montine TJ, Schellenberg GD, Deming Y, Chao MJ, Huentelman M, Martin ER, Hamilton-Nelson K, Shaw LM, Trojanowski JQ, Peskind ER, Cruchaga C, Pericak-Vance MA, Goate AM, Cox NJ, Haines JL, Zetterberg H, Blennow K, Larson EB, Johnson SC, Albert M; Alzheimer’s Disease Genetics Consortium and the Alzheimer’s Disease Neuroimaging Initiative, Bennett DA, Schneider JA, Jefferson AL, Hohman TJ.

Brain. 2019 Sep 1;142(9):2581-2589. doi: 10.1093/brain/awz206.

PMID:
31497858
16.

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.

Shi L, Westwood S, Baird AL, Winchester L, Dobricic V, Kilpert F, Hong S, Franke A, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Buckley NJ, Kate MT, Scheltens P, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lleó A, Alcolea D, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Teunissen CE, Freund-Levi Y, Frölich L, Legido-Quigley C, Barkhof F, Blennow K, Zetterberg H, Baker S, Morgan BP, Streffer J, Visser PJ, Bertram L, Lovestone S, Nevado-Holgado AJ.

Alzheimers Dement. 2019 Sep 5. pii: S1552-5260(19)35118-0. doi: 10.1016/j.jalz.2019.06.4951. [Epub ahead of print]

17.

Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patients.

Leavey N, Hammond SP, Shepstone L, Cross J, Zetterberg H, Cunningham C, MacLullich A, Leiv Otto Watne, Minihane AM, Ballard C, Knapskog AB, Hall R, Howard G, Hammond M, Fox C.

BMC Neurol. 2019 Sep 7;19(1):223. doi: 10.1186/s12883-019-1447-7.

18.

In vivo detection of cerebral tau pathology in long-term survivors of traumatic brain injury.

Gorgoraptis N, Li LM, Whittington A, Zimmerman KA, Maclean LM, McLeod C, Ross E, Heslegrave A, Zetterberg H, Passchier J, Matthews PM, Gunn RN, McMillan TM, Sharp DJ.

Sci Transl Med. 2019 Sep 4;11(508). pii: eaaw1993. doi: 10.1126/scitranslmed.aaw1993.

PMID:
31484787
19.

Growth factors and neurotrophins in patients with stress-related exhaustion disorder.

Sjörs Dahlman A, Blennow K, Zetterberg H, Glise K, Jonsdottir IH.

Psychoneuroendocrinology. 2019 Aug 20;109:104415. doi: 10.1016/j.psyneuen.2019.104415. [Epub ahead of print]

20.

Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood-brain barrier model.

Delsing L, Kallur T, Zetterberg H, Hicks R, Synnergren J.

Fluids Barriers CNS. 2019 Aug 29;16(1):27. doi: 10.1186/s12987-019-0147-4.

21.

Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.

Chatterjee P, Elmi M, Goozee K, Shah T, Sohrabi HR, Dias CB, Pedrini S, Shen K, Asih PR, Dave P, Taddei K, Vanderstichele H, Zetterberg H, Blennow K, Martins RN.

J Alzheimers Dis. 2019;71(3):775-783. doi: 10.3233/JAD-190533.

PMID:
31424403
22.

Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease.

Sjögren M, Soylu-Kucharz R, Dandunna U, Stan TL, Cavalera M, Sandelius Å, Zetterberg H, Björkqvist M.

Neurobiol Dis. 2019 Aug 13;132:104560. doi: 10.1016/j.nbd.2019.104560. [Epub ahead of print]

PMID:
31419548
23.

The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk.

Deming Y, Filipello F, Cignarella F, Cantoni C, Hsu S, Mikesell R, Li Z, Del-Aguila JL, Dube U, Farias FG, Bradley J, Budde J, Ibanez L, Fernandez MV, Blennow K, Zetterberg H, Heslegrave A, Johansson PM, Svensson J, Nellgård B, Lleo A, Alcolea D, Clarimon J, Rami L, Molinuevo JL, Suárez-Calvet M, Morenas-Rodríguez E, Kleinberger G, Ewers M, Harari O, Haass C, Brett TJ, Benitez BA, Karch CM, Piccio L, Cruchaga C.

Sci Transl Med. 2019 Aug 14;11(505). pii: eaau2291. doi: 10.1126/scitranslmed.aau2291.

PMID:
31413141
24.

Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X.

Kagiava A, Richter J, Tryfonos C, Karaiskos C, Heslegrave AJ, Sargiannidou I, Rossor AM, Zetterberg H, Reilly MM, Christodoulou C, Kleopa KA.

Hum Mol Genet. 2019 Aug 14. pii: ddz199. doi: 10.1093/hmg/ddz199. [Epub ahead of print]

PMID:
31411673
25.

Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis.

Gaetani L, Eusebi P, Mancini A, Gentili L, Borrelli A, Parnetti L, Calabresi P, Sarchielli P, Blennow K, Zetterberg H, Di Filippo M.

Mult Scler Relat Disord. 2019 Jul 27;35:228-232. doi: 10.1016/j.msard.2019.07.025. [Epub ahead of print]

PMID:
31404762
26.

Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.

Osborn KE, Alverio JM, Dumitrescu L, Pechman KR; Alzheimer’s Disease Neuroimaging Initiative, Gifford KA, Hohman TJ, Blennow K, Zetterberg H, Jefferson AL.

J Alzheimers Dis. 2019;71(1):281-290. doi: 10.3233/JAD-190077.

PMID:
31381510
27.

Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction.

Pedersen A, Stanne TM, Nilsson S, Klasson S, Rosengren L, Holmegaard L, Jood K, Blennow K, Zetterberg H, Jern C.

J Neurol. 2019 Aug 2. doi: 10.1007/s00415-019-09477-9. [Epub ahead of print]

PMID:
31375988
28.

Plasma neurofilament light chain concentration is increased in anorexia nervosa.

Nilsson IAK, Millischer V, Karrenbauer VD, Juréus A, Salehi AM, Norring C, von Hausswolff-Juhlin Y, Schalling M, Blennow K, Bulik CM, Zetterberg H, Landén M.

Transl Psychiatry. 2019 Aug 1;9(1):180. doi: 10.1038/s41398-019-0518-2.

29.

Screening with a high precision blood-based assay for Alzheimer disease.

Bendlin BB, Zetterberg H.

Neurology. 2019 Aug 1. pii: 10.1212/WNL.0000000000008080. doi: 10.1212/WNL.0000000000008080. [Epub ahead of print] No abstract available.

PMID:
31371570
30.

A tear fluid proteome of Parkinson's disease.

Zetterberg H, Compta Y.

Parkinsonism Relat Disord. 2019 Jun;63:1-2. doi: 10.1016/j.parkreldis.2019.07.028. Epub 2019 Jul 23. No abstract available.

PMID:
31353307
31.

Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression.

De S, Whiten DR, Ruggeri FS, Hughes C, Rodrigues M, Sideris DI, Taylor CG, Aprile FA, Muyldermans S, Knowles TPJ, Vendruscolo M, Bryant C, Blennow K, Skoog I, Kern S, Zetterberg H, Klenerman D.

Acta Neuropathol Commun. 2019 Jul 26;7(1):120. doi: 10.1186/s40478-019-0777-4.

32.

Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease.

Fossati S, Ramos Cejudo J, Debure L, Pirraglia E, Sone JY, Li Y, Chen J, Butler T, Zetterberg H, Blennow K, de Leon MJ.

Alzheimers Dement (Amst). 2019 Jun 28;11:483-492. doi: 10.1016/j.dadm.2019.05.001. eCollection 2019 Dec.

33.

Human cerebrospinal fluid promotes spontaneous gamma oscillations in the hippocampus in vitro.

Bjorefeldt A, Roshan F, Forsberg M, Zetterberg H, Hanse E, Fisahn A.

Hippocampus. 2019 Jul 17. doi: 10.1002/hipo.23135. [Epub ahead of print]

PMID:
31313871
34.

Twin study shows association between monocyte chemoattractant protein-1 and kynurenic acid in cerebrospinal fluid.

Johansson V, Erhardt S, Engberg G, Kegel M, Bhat M, Schwieler L, Blennow K, Zetterberg H, Cannon TD, Wetterberg L, Hultman CM, Landén M.

Eur Arch Psychiatry Clin Neurosci. 2019 Jul 13. doi: 10.1007/s00406-019-01042-9. [Epub ahead of print]

PMID:
31302732
35.

Characterization of Cerebrospinal Fluid BACE1 Species.

Lopez-Font I, Boix CP, Zetterberg H, Blennow K, Sáez-Valero J.

Mol Neurobiol. 2019 Jul 9. doi: 10.1007/s12035-019-01677-8. [Epub ahead of print]

PMID:
31290061
36.

Interleukin 9 alterations linked to alzheimer disease in african americans.

Wharton W, Kollhoff AL, Gangishetti U, Verble DD, Upadhya S, Zetterberg H, Kumar V, Watts KD, Kippels AJ, Gearing M, Howell JC, Parker MW, Hu WT.

Ann Neurol. 2019 Sep;86(3):407-418. doi: 10.1002/ana.25543. Epub 2019 Jul 22.

PMID:
31271450
37.

Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.

Allison SL, Koscik RL, Cary RP, Jonaitis EM, Rowley HA, Chin NA, Zetterberg H, Blennow K, Carlsson CM, Asthana S, Bendlin BB, Johnson SC.

Neuroimage Clin. 2019;23:101895. doi: 10.1016/j.nicl.2019.101895. Epub 2019 Jun 10.

38.

Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches.

Wilke C, Pujol-Calderón F, Barro C, Stransky E, Blennow K, Michalak Z, Deuschle C, Jeromin A, Zetterberg H, Schüle R, Höglund K, Kuhle J, Synofzik M.

Clin Chem Lab Med. 2019 Sep 25;57(10):1556-1564. doi: 10.1515/cclm-2019-0015.

PMID:
31251725
39.

Evolution and clustering of prodromal parkinsonian features in GBA1 carriers.

Mullin S, Beavan M, Bestwick J, McNeill A, Proukakis C, Cox T, Hughes D, Mehta A, Zetterberg H, Schapira AHV.

Mov Disord. 2019 Sep;34(9):1365-1373. doi: 10.1002/mds.27775. Epub 2019 Jun 28.

PMID:
31251436
40.

Sex difference in CHI3L1 expression levels in human brain aging and in Alzheimer's disease.

Sanfilippo C, Castrogiovanni P, Imbesi R, Kazakowa M, Musumeci G, Blennow K, Zetterberg H, Di Rosa M.

Brain Res. 2019 Oct 1;1720:146305. doi: 10.1016/j.brainres.2019.146305. Epub 2019 Jun 24.

PMID:
31247206
41.

Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status.

Palmqvist S, Janelidze S, Stomrud E, Zetterberg H, Karl J, Zink K, Bittner T, Mattsson N, Eichenlaub U, Blennow K, Hansson O.

JAMA Neurol. 2019 Jun 24. doi: 10.1001/jamaneurol.2019.1632. [Epub ahead of print]

42.

SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases.

Paterson RW, Gabelle A, Lucey BP, Barthélemy NR, Leckey CA, Hirtz C, Lehmann S, Sato C, Patterson BW, West T, Yarasheski K, Rohrer JD, Wildburger NC, Schott JM, Karch CM, Wray S, Miller TM, Elbert DL, Zetterberg H, Fox NC, Bateman RJ.

Nat Rev Neurol. 2019 Jul;15(7):419-427. doi: 10.1038/s41582-019-0222-0. Epub 2019 Jun 20. Review.

PMID:
31222062
43.

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.

Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE; and the NFL Group, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landén M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, Pérez-Santiago J, Piehl F, Pijnenburg YAL, Pyykkö OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillbäck T, Stilund M, Sundström P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, Vågberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelsø C, Wild EJ.

JAMA Neurol. 2019 Jun 17. doi: 10.1001/jamaneurol.2019.1534. [Epub ahead of print]

PMID:
31206160
44.

PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation.

Chelban V, Wilson MP, Warman Chardon J, Vandrovcova J, Zanetti MN, Zamba-Papanicolaou E, Efthymiou S, Pope S, Conte MR, Abis G, Liu YT, Tribollet E, Haridy NA, Botía JA, Ryten M, Nicolaou P, Minaidou A, Christodoulou K, Kernohan KD, Eaton A, Osmond M, Ito Y, Bourque P, Jepson JEC, Bello O, Bremner F, Cordivari C, Reilly MM, Foiani M, Heslegrave A, Zetterberg H, Heales SJR, Wood NW, Rothman JE, Boycott KM, Mills PB, Clayton PT, Houlden H; Care4Rare Canada Consortium and the SYNaPS Study Group.

Ann Neurol. 2019 Aug;86(2):225-240. doi: 10.1002/ana.25524. Epub 2019 Jul 1.

45.

Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures.

Mielke MM, Syrjanen JA, Blennow K, Zetterberg H, Vemuri P, Skoog I, Machulda MM, Kremers WK, Knopman DS, Jack C Jr, Petersen RC, Kern S.

Neurology. 2019 Jul 16;93(3):e252-e260. doi: 10.1212/WNL.0000000000007767. Epub 2019 Jun 10.

46.

Serum tau concentration after diving - an observational pilot study.

Rosén A, Oscarsson N, Kvarnström A, Gennser M, Sandström G, Blennow K, Seeman-Lodding H, Zetterberg H.

Diving Hyperb Med. 2019 Jun 30;49(2):88-95. doi: 10.28920/dhm49.2.88-95.

PMID:
31177514
47.

CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.

Jeppsson A, Wikkelsö C, Blennow K, Zetterberg H, Constantinescu R, Remes AM, Herukka SK, Rauramaa T, Nagga K, Leinonen V, Tullberg M.

J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1117-1123. doi: 10.1136/jnnp-2019-320826. Epub 2019 Jun 5.

48.

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.

Vermunt L, Sikkes SAM, van den Hout A, Handels R, Bos I, van der Flier WM, Kern S, Ousset PJ, Maruff P, Skoog I, Verhey FRJ, Freund-Levi Y, Tsolaki M, Wallin ÅK, Olde Rikkert M, Soininen H, Spiru L, Zetterberg H, Blennow K, Scheltens P, Muniz-Terrera G, Visser PJ; Alzheimer Disease Neuroimaging Initiative; AIBL Research Group; ICTUS/DSA study groups.

Alzheimers Dement. 2019 Jul;15(7):888-898. doi: 10.1016/j.jalz.2019.04.001. Epub 2019 Jun 1.

PMID:
31164314
49.

Cerebrospinal Fluid Concentrations of Extracellular Matrix Proteins in Alzheimer's Disease.

Minta K, Portelius E, Janelidze S, Hansson O, Zetterberg H, Blennow K, Andreasson U.

J Alzheimers Dis. 2019;69(4):1213-1220. doi: 10.3233/JAD-190187.

PMID:
31156172
50.

Serum Neurofilament Light Chain Concentration Correlates with Infarct Volume but Not Prognosis in Acute Ischemic Stroke.

Onatsu J, Vanninen R, Jäkälä P, Mustonen P, Pulkki K, Korhonen M, Hedman M, Zetterberg H, Blennow K, Höglund K, Herukka SK, Taina M.

J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2242-2249. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.008. Epub 2019 May 28.

PMID:
31151840

Supplemental Content

Loading ...
Support Center